These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3121845

  • 1. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy.
    Cory-Slechta DA, Weiss B, Cox C.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):804-13. PubMed ID: 3121845
    [Abstract] [Full Text] [Related]

  • 2. Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children.
    Thomas DJ, Chisolm J.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):829-35. PubMed ID: 3098962
    [Abstract] [Full Text] [Related]

  • 3. The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer.
    Seaton CL, Lasman J, Smith DR.
    Toxicol Appl Pharmacol; 1999 Sep 15; 159(3):153-60. PubMed ID: 10486301
    [Abstract] [Full Text] [Related]

  • 4. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
    Sánchez-Fructuoso AI, Cano M, Arroyo M, Fernández C, Prats D, Barrientos A.
    Am J Kidney Dis; 2002 Jul 15; 40(1):51-8. PubMed ID: 12087561
    [Abstract] [Full Text] [Related]

  • 5. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA.
    J Pharmacol Exp Ther; 1988 Jul 15; 246(1):84-91. PubMed ID: 2839672
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of edetate and thiamine for treatment of experimentally induced environmental lead poisoning in cattle.
    Coppock RW, Wagner WC, Reynolds JD, Vogel RS, Gelberg HB, Florence LZ, Wolff WA.
    Am J Vet Res; 1991 Nov 15; 52(11):1860-5. PubMed ID: 1785729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD, Luck ML, Laughlin NK, Smith DR.
    Toxicol Appl Pharmacol; 1999 Dec 15; 161(3):283-93. PubMed ID: 10620486
    [Abstract] [Full Text] [Related]

  • 13. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR, Woolard D, Luck ML, Laughlin NK.
    Toxicol Appl Pharmacol; 2000 Aug 01; 166(3):230-40. PubMed ID: 10906287
    [Abstract] [Full Text] [Related]

  • 14. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
    Sánchez-Fructuoso AI, Blanco J, Cano M, Ortega L, Arroyo M, Fernández C, Prats D, Barrientos A.
    Am J Kidney Dis; 2002 Jul 01; 40(1):59-67. PubMed ID: 12087562
    [Abstract] [Full Text] [Related]

  • 15. Effects of acute and chronic oval exposure of lead on blood pressure and bone mineral density in rats.
    Bagchi D, Preuss HG.
    J Inorg Biochem; 2005 May 01; 99(5):1155-64. PubMed ID: 15833339
    [Abstract] [Full Text] [Related]

  • 16. Occult lead intoxication as a cause of hypertension and renal failure.
    Sánchez-Fructuoso AI, Torralbo A, Arroyo M, Luque M, Ruilope LM, Santos JL, Cruceyra A, Barrientos A.
    Nephrol Dial Transplant; 1996 Sep 01; 11(9):1775-80. PubMed ID: 8918621
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert PanelCosmetic Ingredient Review, Washington DC 20036, USA..
    Int J Toxicol; 2007 Sep 01; 26 Suppl 2():79-112. PubMed ID: 17613133
    [Abstract] [Full Text] [Related]

  • 19. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
    Marija Varnai V, Piasek M, Blanusa M, Matek Sarić M, Juresa D, Kostial K.
    J Appl Toxicol; 2004 Sep 01; 24(2):123-8. PubMed ID: 15052607
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT, Lin JL, Yen TH, Chen KH, Huang YL.
    Nephrol Dial Transplant; 2007 Oct 01; 22(10):2924-31. PubMed ID: 17556414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.